Drug Profile
Research programme: bovine-derived polyclonal antibodies - Immuron
Alternative Names: Bovine colostrum powder therapeutics - Immuron; Hyper immune anti UPEC product - Immuron; IMM 160; IMM 252 (HIV microbicide)Latest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator Immuron
- Developer Immuron; Monash University
- Class Polyclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections; Liver cancer; Urinary tract infections
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for preclinical development in Urinary-tract-infections in Australia (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Liver-cancer in Australia (PO)
- 16 Jul 2016 No recent reports of development identified for research development in HIV-infections in Australia (PO)